11-Oct-21 07:30

Sam Fazeli, Director of Research, Bloomberg Intelligence

Last week, Health Minister Khairy Jamaludin said that the government would procure 150,000 treatment packages of a Covid-19 anti-viral drug produced by Merck called Molnupiravir. The drug is being described by many quarters as a gamechanger in the fight against Covid-19. Based on trials conducted so far, the medication was shown to reduce the risk of hospitalization or death by around 50% in patients with mild-to-moderate symptoms of the virus. We get the lowdown on Molnupiravir from Sam Fazeli, Director of Research at Bloomberg Intelligence.

Image credit: Quality Stock Arts / Shutterstock.com